Aims & Scope

CANCER DIAGNOSIS & PROGNOSIS (CDP) is an international online open-access bimonthly journal designed to bring together original high-quality works and reviews on experimental and clinical research advancing knowledge on the diagnosis and prognosis of all types of human cancer, leukemia, and metastasis.

CDP is aiming at improving prompt disease management and quality of life of cancer patients through a precise early diagnosis and prognosis.

The topics of CDP include 1.

Experimental development of new diagnostic and prognostic biomarkers; 2.

Clinical application of new biomarkers; 3.

Evaluation of combinations of past and emerging biomarkers; 4.

Molecular pathology and proteomics in the discovery of new biomarkers and systemic cancer staging; 5.

Genetic, epigenetic, and chromosomal markers; 6.

Use of biomarkers in the selection of the proper cancer management; 7.

Use of biomarkers in assessing response, restaging, and prognosis after surgery, radiotherapy, chemotherapy, and/or immunotherapy; 8.

Use of diagnostic procedures including combinations of biomarkers and imaging in the selection and assessment of the proper cancer management; 9.

Novel surgery technologies in improving diagnosis and prognosis.

Each submitted article should include a concrete conclusion constituting a “new piece of knowledge” backed by scientific evidence.

View Aims & Scope

Metrics & Ranking

SJR (SCImago Journal Rank)

Year Value
2024 0.430

Quartile

Year Value
2024 Q3

h-index

Year Value
2024 11

Journal Rank

Year Value
2024 13118

Journal Citation Indicator

Year Value
2024 399

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.


SJR (SCImago Journal Rank)

SJR
0.430
First Published: 2024

Quartile

Current Quartile
Q3
First Published: 2024

Similar Journals

Top Journals in Related Fields